Quantitation of left ventricular ejection fraction reserve from early gated regadenoson stress Tc-99m high-efficiency SPECT

J Nucl Cardiol. 2016 Dec;23(6):1251-1261. doi: 10.1007/s12350-016-0519-y. Epub 2016 Jul 7.

Abstract

Background: Ejection fraction (EF) reserve has been found to be a useful adjunct for identifying high risk coronary artery disease in cardiac positron emission tomography (PET). We aimed to evaluate EF reserve obtained from technetium-99m sestamibi (Tc-99m) high-efficiency (HE) SPECT.

Methods: Fifty patients (mean age 69 years) undergoing regadenoson same-day rest (8-11 mCi)/stress (32-42 mCi) Tc-99m gated HE SPECT were enrolled. Stress imaging was started 1 minute after sequential intravenous regadenoson .4 mg and Tc-99m injections, and was composed of five 2 minutes supine gated acquisitions followed by two 4 minutes supine and upright images. Ischemic total perfusion deficit (ITPD) ≥5 % was considered as significant ischemia.

Results: Significantly lower mean EF reserve was obtained in the 5th and 9th minute after regadenoson bolus in patients with significant ischemia vs patients without (5th minute: -4.2 ± 4.6% vs 1.3 ± 6.6%, P = .006; 9th minute: -2.7 ± 4.8% vs 2.0 ± 6.6%, P = .03).

Conclusions: Negative EF reserve obtained between 5th and 9th minutes of regadenoson stress demonstrated best concordance with significant ischemia and may be a promising tool for detection of transient ischemic functional changes with Tc-99m HE-SPECT.

Keywords: Regadenoson Tc-99m high-efficiency SPECT; early stress imaging; image quality; left ventricular ejection fraction reserve.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography / methods*
  • Coronary Artery Disease / complications
  • Coronary Artery Disease / diagnostic imaging
  • Exercise Test / methods*
  • Female
  • Humans
  • Image Enhancement / methods
  • Image Interpretation, Computer-Assisted / methods
  • Male
  • Purines*
  • Pyrazoles*
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Stroke Volume*
  • Technetium Tc 99m Sestamibi*
  • Tomography, Emission-Computed, Single-Photon / methods*
  • Vasodilator Agents
  • Ventricular Dysfunction, Left / diagnostic imaging*
  • Ventricular Dysfunction, Left / etiology

Substances

  • Purines
  • Pyrazoles
  • Radiopharmaceuticals
  • Vasodilator Agents
  • regadenoson
  • Technetium Tc 99m Sestamibi